Global Sex Reassignment Surgery Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Sex Reassignment Surgery Market Research Report 2024
Sex reassignment surgery (SRS), also known as gender reassignment surgery (GRS) and several other names, is a surgical procedure (or procedures) by which a transgender person's physical appearance and function of their existing sexual characteristics are altered to resemble that socially associated with their identified gender. It is part of a treatment for gender dysphoria in transgender people.
According to MRAResearch’s new survey, global Sex Reassignment Surgery market is projected to reach US$ 619.1 million in 2033, increasing from US$ 236.7 million in 2022, with the CAGR of 14.2% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sex Reassignment Surgery market research.
Key companies engaged in the Sex Reassignment Surgery industry include Mount Sinai Centre for Transgender Medicine and Surgery (CTMS), Transgender Surgery Institute of Southern California, Rumercosmetics, Chettawut Plastic Surgery centre, Phuket International Aesthetic Centre, Sava Perovic Foundation Surgery, Yeson Voice centre and Bupa Cromwell Hospital, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Sex Reassignment Surgery were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sex Reassignment Surgery market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Sex Reassignment Surgery market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Mount Sinai Centre for Transgender Medicine and Surgery (CTMS)
Transgender Surgery Institute of Southern California
Rumercosmetics
Chettawut Plastic Surgery centre
Phuket International Aesthetic Centre
Sava Perovic Foundation Surgery
Yeson Voice centre
Bupa Cromwell Hospital
Segment by Type
Male to Female
Female to Male
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Sex Reassignment Surgery report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Sex Reassignment Surgery market is projected to reach US$ 619.1 million in 2033, increasing from US$ 236.7 million in 2022, with the CAGR of 14.2% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sex Reassignment Surgery market research.
Key companies engaged in the Sex Reassignment Surgery industry include Mount Sinai Centre for Transgender Medicine and Surgery (CTMS), Transgender Surgery Institute of Southern California, Rumercosmetics, Chettawut Plastic Surgery centre, Phuket International Aesthetic Centre, Sava Perovic Foundation Surgery, Yeson Voice centre and Bupa Cromwell Hospital, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Sex Reassignment Surgery were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sex Reassignment Surgery market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Sex Reassignment Surgery market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Mount Sinai Centre for Transgender Medicine and Surgery (CTMS)
Transgender Surgery Institute of Southern California
Rumercosmetics
Chettawut Plastic Surgery centre
Phuket International Aesthetic Centre
Sava Perovic Foundation Surgery
Yeson Voice centre
Bupa Cromwell Hospital
Segment by Type
Male to Female
Female to Male
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Sex Reassignment Surgery report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source